| scholarly article | Q13442814 |
| P50 | author | James David Chappell | Q91489970 |
| P2093 | author name string | Joshua D Doyle | |
| Terence S Dermody | |||
| Nobuhiko Katunuma | |||
| M Kay Washington | |||
| Elizabeth M Johnson | |||
| J Denise Wetzel | |||
| R Paul McClung | |||
| P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
| The Sequence of the Human Genome | Q22065842 | ||
| Human cathepsin S: chromosomal localization, gene structure, and tissue distribution | Q24310666 | ||
| L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L | Q24531160 | ||
| Lysosomal cysteine proteases: facts and opportunities | Q24535678 | ||
| Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing) | Q27486833 | ||
| Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease | Q28117779 | ||
| Emerging roles for cysteine proteases in human biology | Q28306260 | ||
| Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection | Q28588877 | ||
| Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and perturbation of hair follicle cycling | Q28590536 | ||
| Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo | Q28595026 | ||
| Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus | Q28613227 | ||
| Virus entry: open sesame | Q29619349 | ||
| The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B. | Q30321505 | ||
| Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. | Q30321506 | ||
| Independent regulation of reovirus membrane penetration and apoptosis by the mu1 phi domain | Q33396212 | ||
| Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy. | Q33415278 | ||
| Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease | Q33914633 | ||
| Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry | Q33920306 | ||
| Type 3 reovirus neuroinvasion after intramuscular inoculation: direct invasion of nerve terminals and age-dependent pathogenesis | Q33963215 | ||
| Two Modes of Entry of Reovirus Particles into L Cells | Q41031906 | ||
| Expression of rat cathepsin S in phagocytic cells | Q41226814 | ||
| Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain | Q41422715 | ||
| Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein | Q42042006 | ||
| Junctional adhesion molecule-A is required for hematogenous dissemination of reovirus | Q42085912 | ||
| Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein | Q42136372 | ||
| Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. | Q43832068 | ||
| Structure-based design of specific cathepsin inhibitors and their application to protection of bone metastases of cancer cells | Q43857553 | ||
| Specific role for cathepsin S in the generation of antigenic peptides in vivo | Q43867816 | ||
| Thymocyte expression of cathepsin L is essential for NKT cell development | Q44170965 | ||
| Experimental reovirus type 3-induced murine biliary tract disease | Q44228488 | ||
| Age dependent susceptibility to Reovirus type 3 encephalitis: role of viral and host factors | Q44434583 | ||
| Molecular basis of viral neurotropism: experimental reovirus infection | Q44912636 | ||
| Protein sigma 1 is the reovirus cell attachment protein | Q45148582 | ||
| A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. | Q45420084 | ||
| Putative autocleavage of reovirus mu1 protein in concert with outer-capsid disassembly and activation for membrane permeabilization | Q47845847 | ||
| Chronic obstructive jaundice induced by Reovirus type 3 in weanling mice. | Q54412945 | ||
| The mechanisms of reovirus uncoating and gene activation in vivo | Q67294193 | ||
| Participation of cathepsin B in processing of antigen presentation to MHC class II | Q70494348 | ||
| Fate of parental reovirus in infected cell | Q70731978 | ||
| Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process | Q70779231 | ||
| Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3 | Q71161459 | ||
| Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases | Q71185919 | ||
| Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo | Q73077056 | ||
| Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice | Q74595052 | ||
| The M2 gene segment is involved in the capacity of reovirus type 3Abney to induce the oily fur syndrome in neonatal mice, a S1 gene segment-associated phenotype | Q78724876 | ||
| Cathepsin L is essential for onset of autoimmune diabetes in NOD mice | Q34014524 | ||
| Reovirus variants selected for resistance to ammonium chloride have mutations in viral outer-capsid protein sigma3. | Q34301756 | ||
| Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. | Q34343810 | ||
| The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics | Q34416331 | ||
| Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c | Q34457741 | ||
| Cathepsin L activity controls adipogenesis and glucose tolerance | Q34654358 | ||
| Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor design | Q34754118 | ||
| Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease | Q35095524 | ||
| Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly | Q35877228 | ||
| Mutations in reovirus outer-capsid protein sigma3 selected during persistent infections of L cells confer resistance to protease inhibitor E64 | Q35887561 | ||
| Basic statistical considerations in virological experiments | Q35990979 | ||
| The biliary tract in acute murine reovirus 3 infection. Light and electron microscopic study | Q36051629 | ||
| The lysosomal cysteine proteases in MHC class II antigen presentation | Q36266499 | ||
| Endosomal proteases in antigen presentation | Q36336164 | ||
| Molecular basis of reovirus virulence. Role of the M2 gene | Q36344079 | ||
| Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands | Q36370268 | ||
| Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice | Q36399901 | ||
| Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation | Q36475793 | ||
| Cysteine cathepsins: multifunctional enzymes in cancer | Q36600996 | ||
| Association of the reovirus S1 gene with serotype 3-induced biliary atresia in mice. | Q36636134 | ||
| Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. | Q36686120 | ||
| Emerging roles of cysteine cathepsins in disease and their potential as drug targets. | Q36740577 | ||
| Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles | Q36826294 | ||
| Cathepsin cysteine proteases in cardiovascular disease. | Q36830621 | ||
| Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. | Q36915422 | ||
| Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expression | Q37015016 | ||
| New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics | Q37232893 | ||
| Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers | Q37500830 | ||
| Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption | Q39684830 | ||
| Role of endocytosis and cathepsin-mediated activation in Nipah virus entry | Q40002207 | ||
| SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells | Q40341738 | ||
| The delta region of outer-capsid protein micro 1 undergoes conformational change and release from reovirus particles during cell entry. | Q40344603 | ||
| Endocytosis by random initiation and stabilization of clathrin-coated pits | Q40520631 | ||
| Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus. | Q40530759 | ||
| Isolation and molecular characterization of a novel type 3 reovirus from a child with meningitis | Q40561414 | ||
| Cathepsin S supports acid-independent infection by some reoviruses | Q40608252 | ||
| Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells | Q40734800 | ||
| Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis | Q40735691 | ||
| A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation | Q40746014 | ||
| 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum | Q40804350 | ||
| Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening | Q40845786 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| Reovirus | Q69812835 | ||
| P304 | page(s) | 9630-9640 | |
| P577 | publication date | 2009-07-29 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis | |
| P478 | volume | 83 |
| Q38632786 | A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes |
| Q39406187 | Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment. |
| Q42288185 | Amino acid substitutions in σ1 and μ1 outer capsid proteins are selected during mammalian reovirus adaptation to Vero cells |
| Q28299264 | Apoptosis induction influences reovirus replication and virulence in newborn mice |
| Q39406121 | Cell entry-associated conformational changes in reovirus particles are controlled by host protease activity |
| Q64991702 | Ectromelia virus suppresses expression of cathepsins and cystatins in conventional dendritic cells to efficiently execute the replication process. |
| Q53204721 | Expression profile of genes involved in pathogenesis of pediatric Crohn's disease. |
| Q37123318 | Genetic determinants of reovirus pathogenesis in a murine model of respiratory infection |
| Q42351663 | In search of cathepsins: how reovirus enters host cells |
| Q35868303 | Molecular determinants of proteolytic disassembly of the reovirus outer capsid. |
| Q26775033 | Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants |
| Q36494593 | Reovirus receptors, cell entry, and proapoptotic signaling. |
| Q98227509 | Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19? |
| Q59349217 | Structural and Functional Features of the Reovirus σ1 Tail |
| Q42210794 | The Nogo receptor NgR1 mediates infection by mammalian reovirus. |
| Q91792977 | The Orchestra of Reovirus Cell Entry |
| Q40916513 | The crucial role of bile acids in the entry of porcine enteric calicivirus |
| Q38959464 | The reovirus sigma1s protein is a determinant of hematogenous but not neural virus dissemination in mice |
| Q38072995 | The role of cysteine proteinases and their inhibitors in the host-pathogen cross talk |
Search more.